29 research outputs found

    Adenosine์˜ cAMP ์‹ ํ˜ธ๊ฒฝ๋กœ ํ™œ์„ฑํ™”๋ฅผ ํ†ตํ•œ ๊ฒ€์€์ฝฉ์˜ ํ•ญํ˜ˆ์†ŒํŒ ์ž‘์šฉ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์•ฝํ•™๊ณผ, 2013. 2. ์ •์ง„ํ˜ธ.๋งŽ์€ ์ž„์ƒ์—ฐ๊ตฌ๋“ค์„ ํ†ตํ•ด์„œ ์ฝฉ (Glycine max)์ด ์‹ฌํ˜ˆ๊ด€๊ณ„์— ์œ ์ตํ•œ ์˜ํ–ฅ์„ ์ค€๋‹ค๋Š” ์‚ฌ์‹ค์ด ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ๋‹ค์–‘ํ•œ ์ฝฉ๋“ค ์ค‘์—์„œ ๊ฒ€์€์ฝฉ์€ ํ•ญ์‚ฐํ™”, ํ•ญ์—ผ์ฆ, ํ•ญ์•”์ž‘์šฉ ๋“ฑ์— ์žˆ์–ด์„œ ๋‹ค๋ฅธ ์ฝฉ๋“ค์— ๋น„ํ•ด ๊ฐ•ํ•œ ์ƒ๋ฆฌํ™œ์„ฑ์„ ๋ณด์ธ๋‹ค๋Š” ๋ณด๊ณ ๋“ค์ด ์žˆ์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ๊ฒ€์€์ฝฉ์ด ์‹ฌํ˜ˆ๊ด€๊ณ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์— ๋Œ€ํ•œ ์—ฐ๊ตฌ๋Š” ์‹ฌ๋„ ์žˆ๊ฒŒ ์ด๋ฃจ์–ด์ง€์ง€ ์•Š์•˜๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์ด ํ˜ˆ์ „์งˆํ™˜์— ์žˆ์–ด์„œ ์ฃผ์š”ํ•œ ์—ญํ• ์„ ํ•˜๋Š” ํ˜ˆ์†ŒํŒ ํ™œ์„ฑํ™”์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์— ๋Œ€ํ•ด ์—ฐ๊ตฌํ•˜์˜€๋‹ค. ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์€ collagen์— ์˜ํ•œ ํ˜ˆ์†ŒํŒ ์‘์ง‘์— ๋Œ€ํ•ด ๊ฐ•ํ•œ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณด์ธ ๋ฐ˜๋ฉด, ๋…ธ๋ž€์ฝฉ ์ถ”์ถœ๋ฌผ์€ ์–ต์ œํšจ๊ณผ๋ฅผ ๋ณด์ด์ง€ ์•Š์•˜๋‹ค. ๋˜ํ•œ ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์€ ํ˜ˆ์†ŒํŒ๊ณผ ๋‹ค๋ฅธ ํ˜ˆ๊ตฌ ์„ธํฌ ๋ฐ ํ˜ˆ๊ด€์กฐ์ง๊ณผ์˜ ์ƒํ˜ธ์ž‘์šฉ์— ๊ด€์—ฌํ•˜๋Š” serotonin ๋ถ„๋น„, P-selectin ๋ฐœํ˜„, thromboxane A2 ์ƒ์„ฑ๋„ ์–ต์ œํ•˜์˜€๋‹ค. ์ด๋Ÿฌํ•œ in vitro ์‹คํ—˜ ๊ฒฐ๊ณผ๋“ค์€ ex vivo ํ˜ˆ์†ŒํŒ ์‘์ง‘ ์‹คํ—˜๊ณผ in vivo ํ˜ˆ์ „ ์ƒ์„ฑ ์‹œํ—˜๊ณ„๋ฅผ ํ†ตํ•ด ๊ฒ€์ฆ๋˜์—ˆ๋‹ค. ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์„ ๊ฒฝ๊ตฌ ํˆฌ์—ฌํ•œ ๊ฒฝ์šฐ collagen์— ์˜ํ•œ ํ˜ˆ์†ŒํŒ ์‘์ง‘์„ ์–ต์ œํ•˜์˜€์œผ๋ฉฐ, FeCl3๋กœ ์œ ๋„๋œ ์ •๋งฅ ํ˜ˆ์ „ ์ƒ์„ฑ ๋˜ํ•œ ์ €ํ•ดํ•˜์˜€๋‹ค. ๋ฐ˜๋ฉด, ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์€ ํ•ญํ˜ˆ์†ŒํŒ ์ž‘์šฉ์˜ ๋Œ€ํ‘œ์ ์ธ ๋ถ€์ž‘์šฉ์ธ ํ˜ˆ์•ก์‘๊ณ ์ด์ƒ ๋ฐ ์ถœํ˜ˆ์—๋Š” ์˜ํ–ฅ์„ ์ฃผ์ง€ ์•Š์•˜๋‹ค. ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋Š” ์‹ฌํ˜ˆ๊ด€๊ณ„ ์งˆํ™˜์˜ ์˜ˆ๋ฐฉ ๋ฐ ํ˜ˆํ–‰ ๊ฐœ์„ ์— ์žˆ์–ด์„œ ๊ฒ€์€์ฝฉ์˜ ํ™œ์šฉ ๊ฐ€๋Šฅ์„ฑ์„ ๋’ท๋ฐ›์นจํ•œ๋‹ค. ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์˜ ํ•ญํ˜ˆ์†ŒํŒ ์ž‘์šฉ์— ๋Œ€ํ•œ ํ™œ์„ฑ์„ฑ๋ถ„์˜ ๋ถ„๋ฆฌ๋Š” collagen์— ์˜ํ•œ ํ˜ˆ์†ŒํŒ ์‘์ง‘ ์–ต์ œ ํšจ๊ณผ๋ฅผ ํ† ๋Œ€๋กœ bioassay-directed fractionation์„ ํ†ตํ•ด ์ด๋ฃจ์–ด์กŒ๋‹ค. ๋‹จ์ผ ํ™œ์„ฑ์„ฑ๋ถ„์œผ๋กœ ๋ถ„๋ฆฌ๋œ ๋ถ„ํš์€ NMR ๋ถ„์„๊ณผ ESI-MS ๋ถ„์„์„ ํ†ตํ•ด adenosine์œผ๋กœ ํ™•์ธ๋˜์—ˆ์œผ๋ฉฐ, HPLC-UV ๋ถ„์„๊ณผ ํ˜ˆ์†ŒํŒ ์‘์ง‘ ์–ต์ œ ํ™œ์„ฑ์„ ๋น„๊ตํ•˜์—ฌ ๊ฒ€์ฆํ•˜์˜€๋‹ค. ์ด๋ฅผ ํ† ๋Œ€๋กœ ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์˜ ํ•ญํ˜ˆ์†ŒํŒ ์ž‘์šฉ์— ๋Œ€ํ•œ ์ž‘์šฉ๊ธฐ์ „ ๋ฐ adenosine์˜ ์—ญํ• ์— ๋Œ€ํ•œ ์—ฐ๊ตฌ๋ฅผ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์€ cAMP ์‹ ํ˜ธ๊ฒฝ๋กœ๋ฅผ ๋งค๊ฐœ๋กœ ์„ธํฌ ๋‚ด calcium ์ฆ๊ฐ€, GP IIb/IIIa ๋ฐœํ˜„, fibrinogen ๋ถ€์ฐฉ์„ ์ €ํ•ดํ•˜์˜€์œผ๋ฉฐ, ์ตœ์ข…์ ์œผ๋กœ ํ˜ˆ์†ŒํŒ์˜ ๋ถ€์ฐฉ ๋ฐ ์‘์ง‘์„ ์–ต์ œํ•˜์˜€๋‹ค. ๋˜ํ•œ adenosine์— ์˜ํ•ด ํ™œ์„ฑํ™”๋˜์–ด cAMP๋ฅผ ์ƒ์„ฑํ•˜๋Š” adenylyl cyclase์— ๋Œ€ํ•œ ๊ธธํ•ญ์ œ๋“ค์„ ์ „์ฒ˜๋ฆฌํ•œ ๊ฒฐ๊ณผ, adenosine ๋ฐ ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์— ์˜ํ•œ ํ˜ˆ์†ŒํŒ ํ™œ์„ฑํ™” ์–ต์ œ ํšจ๊ณผ๋“ค์ด ์ €ํ•ด๋˜์—ˆ๋‹ค. ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋“ค์€ ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์— ์˜ํ•œ ํ•ญํ˜ˆ์†ŒํŒ ์ž‘์šฉ์— ์žˆ์–ด์„œ ํ™œ์„ฑ์„ฑ๋ถ„์ธ adenosine์˜ cAMP ์‹ ํ˜ธ๊ฒฝ๋กœ ํ™œ์„ฑํ™”๊ฐ€ ์ฃผ์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค๋Š” ๊ฒƒ์„ ๋ณด์—ฌ์ฃผ์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•˜์—ฌ ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์— ์˜ํ•œ ํ•ญํ˜ˆ์†ŒํŒ ์ž‘์šฉ์˜ ๊ธฐ์ „์„ ๊ทœ๋ช…ํ•˜์˜€์œผ๋ฉฐ, ์ฝฉ์—์„œ adenosine์˜ ์ƒ๋ฆฌ์  ํ™œ์„ฑํšจ๊ณผ์— ๋Œ€ํ•œ ํ™œ์„ฑ์„ฑ๋ถ„์œผ๋กœ์„œ์˜ ์—ญํ• ์„ ์ œ์‹œํ•˜์˜€๋‹ค.Many clinical trials have demonstrated the beneficial effects of soybean (Glycine max) on general cardiovascular health. Among a variety of soybeans, black soybean is known to display diverse biological activities superior to yellow or green soybeans such as in antioxidant, anti-inflammatory and anticancer activities. However, few studies have been directed on the effect of black soybean on cardiovascular function. In this study, we aimed to investigate the effect of black soybean extract (BB) on platelet activation, a key contributor to thrombotic diseases. In the freshly isolated human platelets, BB has shown potent inhibitory activity on collagen-induced platelet aggregation while yellow soybean extract had only marginal activity. BB also attenuated serotonin secretion and P-selectin expression, important factors for the platelet-tissue interaction along with thromboxane A2 formation. These in vitro results were further confirmed in ex vivo platelet aggregation measurement and in vivo venous thrombosis model where oral administration of BB reduced collagen-induced platelet aggregation and FeCl3-induced thrombus formation significantly. Of particular note, administration of BB didn't increase coagulation disorder and bleeding risks, a common and severe side effect of antiplatelet drugs. A potential active ingredient for anti-platelet effects of BB was isolated and identified to be adenosine through bioassay-directed fractionation and NMR and ESI-MS analysis. These results indicate that black soybean can be a novel dietary supplement for the prevention of cardiovascular risks and the improvement of blood circulation. We further elucidated the molecular mechanism of BB-mediated anti-platelet activity and demonstrated the significant role of adenosine in BB-induced health effects. Adenosine-cAMP signaling is found to be responsible for BB-mediated effects, resulting in inhibition of collagen-stimulated platelet activation such as intraplatelet calcium increase, adhesion receptor GP IIb/IIIa expression, fibrinogen binding and further platelet adhesion/aggregation. Taken together, we provide a complete understanding for molecular mechanism of BB-induced anti-platelet activity and a new insight into the role of adenosine as a bioactive compound in soybeans.์ดˆ ๋ก i ๋ชฉ ์ฐจ iii List of Figures v List of Abbreviations vii ์„œ ๋ก  1 I. ์‹ฌํ˜ˆ๊ณ„์งˆํ™˜๊ณผ ํ˜ˆ์†ŒํŒ 1 ์‹ฌํ˜ˆ๊ด€๊ณ„ ์งˆํ™˜๊ณผ ํ˜ˆ์ „์งˆํ™˜ 1 ํ˜ˆ์ „ ์ƒ์„ฑ์—์„œ์˜ ํ˜ˆ์†ŒํŒ์˜ ์—ญํ•  2 ์‹ฌํ˜ˆ๊ด€๊ณ„ ์งˆํ™˜์—์„œ์˜ ํ•ญํ˜ˆ์†ŒํŒ์ œ ์ ์šฉ 3 II. ์ฝฉ๊ณผ ๊ฒ€์€์ฝฉ 6 ์ฝฉ์˜ ์ƒ๋ฆฌํ™œ์„ฑ 6 ๊ฒ€์€์ฝฉ์˜ ์ƒ๋ฆฌํ™œ์„ฑ 6 ์ฝฉ์˜ ํ™œ์„ฑ์„ฑ๋ถ„ 7 III. ์—ฐ๊ตฌ ๋ชฉ์  8 ์‹ค ํ—˜ ๋ฐฉ ๋ฒ• 10 I. ์‹œ์•ฝ ๋ฐ ์‹œ๋ฃŒ ์ค€๋น„ 10 ์‹œ์•ฝ 10 ์ฝฉ์˜ ์ถ”์ถœ ๋ฐ ๋ถ„๋ฆฌ 11 ํ˜ˆ์•ก ๋ฐ ํ˜ˆ์†ŒํŒ ์ค€๋น„ 11 II. ํ˜ˆ์†ŒํŒ์˜ ํ™œ์„ฑํ™” ์ธก์ • 12 ํ˜ˆ์†ŒํŒ ์‘์ง‘ ์ธก์ • ๋ฐ ๊ด€์ฐฐ 12 P-selectin์˜ ๋ฐœํ˜„ ์ธก์ • 13 Serotonin์˜ ๋ถ„๋น„ ์ธก์ • 13 Thromboxane A2 ์ƒ์„ฑ ์ธก์ • 14 II. ๋™๋ฌผ ์‹คํ—˜ 14 In vivo ์ •๋งฅ ํ˜ˆ์ „ ์ƒ์„ฑ ์ธก์ • ๋ฐ ๊ด€์ฐฐ 14 Clotting time ์ธก์ • 15 Bleeding time ์ธก์ • 16 III. ํ™œ์„ฑ์„ฑ๋ถ„ ๋ถ„๋ฆฌ ๋ฐ ๋ถ„์„ 16 ํ™œ์„ฑ์„ฑ๋ถ„ ๋ถ„๋ฆฌ 16 ํ™œ์„ฑ์„ฑ๋ถ„ ๋ถ„์„ 17 ํ˜ˆ์ค‘ adenosine ๋ถ„์„ 17 Adenosine์˜ ํ˜ˆ์ค‘ ์•ˆ์ •์„ฑ ์ธก์ • 18 IV. ์ž‘์šฉ๊ธฐ์ „ ์—ฐ๊ตฌ 18 ํ˜ˆ์†ŒํŒ-collagen ๋ถ€์ฐฉ ์ธก์ • 18 ์„ธํฌ ๋‚ด Ca2+ ๋†๋„ ์ธก์ • 19 GP IIb/IIIa ๋ฐœํ˜„ ์ธก์ • 19 cAMP ์ธก์ • 20 Fibrinogen binding ์ธก์ • 20 V. ํ†ต๊ณ„์ฒ˜๋ฆฌ 21 ์‹ค ํ—˜ ๊ฒฐ ๊ณผ 22 I. ์ฝฉ ์ถ”์ถœ๋ฌผ์˜ ํ•ญํ˜ˆ์†ŒํŒ ๋ฐ ํ•ญํ˜ˆ์ „ ์ž‘์šฉ 22 II. ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์˜ ํ™œ์„ฑ์„ฑ๋ถ„ ๋ถ„๋ฆฌ ๋ฐ ๋ถ„์„ 34 III. ๊ฒ€์€์ฝฉ ์ถ”์ถœ๋ฌผ์˜ ์ž‘์šฉ ๊ธฐ์ „ ์—ฐ๊ตฌ 44 ๊ณ  ์ฐฐ 58 ์ฐธ ๊ณ  ๋ฌธ ํ—Œ 66 Abstract 79Docto

    Cyclin-dependent protein kinase Cdk2 plays an essential role in etoposide-induced apoptosis in HeLa cells Etoposide์— ์˜ํ•ด ์œ ๋„๋œ HeLa cells์˜ apoptosis ๊ณผ์ •์—์„œ CDKs์˜ ๊ธฐ๋Šฅ์  ์—ญํ•  ๊ทœ๋ช…์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    Thesis (master`s)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์•ฝํ•™๊ณผ ์ƒ๋ฌผํ™”ํ•™์ „๊ณต,2002.Maste

    ๊ธฐ์—…๋‹ค๊ฐํ™”์™€ ์˜์—…ํ™œ๋™ ํ˜„๊ธˆํ๋ฆ„ ์กฐ์ •

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ฒฝ์˜๋Œ€ํ•™ ๊ฒฝ์˜ํ•™๊ณผ,2020. 2. ์ด์šฉ๊ทœ.This study examines the existence of possible association between corporate diversification and firms tendency to inflate reported cash from operations(CFO) in the statement of cash flow. Cash flow management is distinct from earnings management in an aspect that it looks at managers manipulation of CFO on financial statement by classification and timing, alternative to accruals. Diversification is positively related to abnormal level of CFO, but their statistical significance is slightly mere in the full sample, if no adjustment is done to a specific firm quality. Nevertheless, from the testing of the sub-samples separately distinguished for higher level of financial distress or greater CFO value relevance to firms stock return, I was able to observe statistically stronger positive relationship between diversification and upward management of CFO.๋ณธ ๋…ผ๋ฌธ์€ ๊ธฐ์—…๋‹ค๊ฐํ™”์™€ ๊ธฐ์—…์˜ ํ˜„๊ธˆํ๋ฆ„ํ‘œ ์ƒ ์˜์—…ํ˜„๊ธˆํ๋ฆ„ ๋ณด๊ณ ๋ฅผ ์กฐ์ •ํ•˜๋Š” ๊ฒฝํ–ฅ๊ณผ์˜ ๊ด€๊ณ„์— ๋Œ€ํ•˜์—ฌ ์—ฐ๊ตฌํ•œ๋‹ค. ์˜์—…ํ˜„๊ธˆํ๋ฆ„ ์กฐ์ •์€ ๋ฐœ์ƒ์•ก๋ณ€ํ™”์— ์ดˆ์ ์„ ๋งž์ถ”๋Š” ์ด์ต์กฐ์ •๊ณผ๋Š” ๋‹ฌ๋ฆฌ ๊ฒฝ์˜์ง„์˜ ์žฌ๋ฌด์ œํ‘œ์ƒ์˜ ํ˜„๊ธˆํ๋ฆ„ ๋ถ„๋ฅ˜์™€ ๋ณด๊ณ  ์‹œ์ ์˜ ์ฐจ์ด๋ฅผ ํ†ตํ•˜์—ฌ ์‹คํ˜„๋œ๋‹ค. ๋ณธ ๋…ผ๋ฌธ์€ ๊ธฐ์—…์ด ๋‹ค๊ฐํ™”๋ฅผ ํ†ตํ•˜์—ฌ ํ˜„๊ธˆํ๋ฆ„ ์กฐ์ •์— ์œ ๋ฆฌํ•œ ํ™˜๊ฒฝ๊ณผ ๊ธฐํšŒ๋ฅผ ๊ฐ€์งˆ ๋•Œ ํ˜„๊ธˆํ๋ฆ„ ์กฐ์ •์— ์ž„ํ•˜๋Š”์ง€์— ๋Œ€ํ•˜์—ฌ ๋ถ„์„ํ•œ๋‹ค. ๊ธฐ์—…๋‹ค๊ฐํ™”๋Š” ์žฌ๋Ÿ‰์  ์˜์—…ํ˜„๊ธˆํ๋ฆ„๊ณผ ์–‘์˜ ๊ด€๊ณ„๋ฅผ ๊ฐ€์ง€๋‚˜ ๊ทธ ํ†ต๊ณ„์  ์œ ์˜๋ฏธ์„ฑ์€ ๊ธฐ์—… ์ „์ฒด๋ฅผ ๋ณธ ์ƒ˜ํ”Œ์—์„œ๋Š” ๊ทธ ํฌ๊ธฐ๊ฐ€ ์•„์ง ๋ฏธ๋ฏธํ•˜๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ๊ธฐ์—…์ด ์žฌ๋ฌด์  ๋ถˆ๊ฑด์ „์„ฑ์ด ๋†’์€ ๊ฒฝ์šฐ ๋˜๋Š” ๊ธฐ์—…์˜ ์˜์—…ํ˜„๊ธˆํ๋ฆ„์ด ์ฃผ๊ฐ€์™€ ๊ด€๋ จ์„ฑ์ด ์ƒ๋Œ€์ ์œผ๋กœ ๋†’์€ ๊ฒฝ์šฐ ๋‹ค๊ฐํ™”์™€ ์˜์—…ํ˜„๊ธˆํ๋ฆ„ ์ƒํ–ฅ์กฐ์ •๊ณผ์˜ ์–‘์˜ ๊ด€๊ณ„๊ฐ€ ๋” ์ปค์ง€๋Š” ๊ฒƒ์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ๋‹ค. ๋˜ํ•œ ๊ธฐ์—… ์ง€๋ฐฐ๊ตฌ์กฐ์˜ ์งˆ์„ ํ†ต์ œํ•˜๋”๋ผ๋„ ๊ธฐ์—…๋‹ค๊ฐํ™”์™€ ์˜์—…ํ˜„๊ธˆํ๋ฆ„ ์กฐ์ •์˜ ์–‘์˜ ๊ด€๊ณ„๊ฐ„์˜ ์œ ์˜๋ฏธ์„ฑ์ด ์ง€์†์ ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค.1. Introduction 1 2. Literature Review 5 2.1. Earnings Management 5 2.2. Cash Flow Management 7 2.3. Corporate Diversification 9 3. Hypotheses Development 11 4. Sample 14 5. Research Design 15 6. Empirical Results 18 7. Conclusion 23 Appendix 25 8. Reference 27 ๊ตญ๋ฌธ์ดˆ๋ก 38Maste

    ๊ธˆ์€ํ™”๋กœ๋ถ€ํ„ฐ์˜ ๋ถ„๋ฆฌ ์„ฑ๋ถ„์ด shear stress์— ์˜ํ•œ ํ˜ˆ์†ŒํŒ ํ™œ์„ฑ ์–ต์ œ์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์•ฝํ•™๊ณผ,2008.2.Maste

    ํ˜„๋Œ€ ๋„์‹œ์—์„œ ํ•œ์˜ฅ์˜ ์˜๋ฏธ : ์„œ์šธ ๋ถ์ดŒ์˜ ์‚ฌ๋ก€ ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ธ๋ฅ˜ํ•™๊ณผ ์ธ๋ฅ˜ํ•™์ „๊ณต,2003.Maste

    A simulation study of the semileptonic decay B - l v at the BELLE experiment

    No full text
    Thesis (master`s)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๋ฌผ๋ฆฌํ•™๊ณผ,1996.Maste

    ์ถฉ์ฒญ๋‚จ๋„ ์žฌ๋‚œ์•ˆ์ „์—ฐ๊ตฌ์„ผํ„ฐ ์†Œ์‹์ง€ ์ œ2ํ˜ธ-์šฐ๋ฆฌ๋‚˜๋ผ์˜ ์ง€์ง„๋ฐฉ์žฌ ์ •์ฑ…๊ณผ ๋Œ€์‘๋ฐฉํ–ฅ

    No full text
    ์ง€์ง„ ๋ฐ ์ง€์ง„ํŒŒ์˜ ์†์„ฑ์„ ์‚ดํŽด๋ณด๊ณ , ๊ทธ๋™์•ˆ ์šฐ๋ฆฌ๋‚˜๋ผ์˜ ์ง€์ง„๋ฐฉ์žฌ ์ •์ฑ… ํ๋ฆ„๊ณผ ๋Œ€์‘๋ฐฉํ–ฅ ๋ชจ์ƒ‰ 1. ๋ฐฐ๊ฒฝ ๋ฐ ํ•„์š”์„ฑ 2. ์ง€์ง„๊ณผ ์ง€์ง„ํŒŒ 3. 1900๋…„ ์ดํ›„ ๊ตญ๋‚ด์™ธ ์ฃผ์š” ์ง€์ง„์‚ฌ๋ก€ 4. ์šฐ๋ฆฌ๋‚˜๋ผ ์ง€์ง„๋ฐฉ์žฌ ์ •์ฑ…์˜ ๋ณ€ํ™”์ถ”

    Effect of External Magnetic Field on Reduction Rate of Magnetite Ore

    No full text
    MasterThe reduction behavior of magnetite by hydrogen and H2-CO gas mixtures with applied magnetic field was investigated. Metallization of magnetite under Curie temperature with different external magnetic field strength and H2/CO gas ratio were investigated by thermo gravimetric analysis, TGA. The reduction rate increased with external magnetic field and hydrogen gas atmosphere. There was no wustite formation at below Curie temperature of magnetite. In order to find out external magnetic field effect on reduction of magnetite, two type of magnetite were utilized, pellet and powder. When powdered sample of magnetite were used, it was possible to observe enhancements of the reduction rate. Because the particles in the presence of an external magnetic field had highly exposed surface area to the reduction gas. In addition, the effect of reduction temperature, reducing agents, ore types, particle size, and specimen shape on the metallization behavior of magnetite below the Curie temperature with different external magnetic field strengths were investigated visually. The elemental distribution in the reduced magnetite were clarified using the BET, XRD, SEM, and EPMA method

    ๋ถํ•œ ์ง€ํ•˜ ๋Œ€๊ทœ๋ชจ ๋ฐœํŒŒ์˜ ๋ฐœํŒŒ์› ํŠน์„ฑ ๋ฐ ํ•œ๋ฐ˜๋„ ์ฃผ๋ณ€ ์ง€๊ฐ ์†๋„ ๊ตฌ์กฐ ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์ž์›๊ณตํ•™๊ณผ, 2011.2. ์‹ ์ฐฝ์ˆ˜.Docto

    ํšŒ์ ˆ์ง€์˜คํ† ๋ชจ๊ทธ๋ž˜ํ”ผ๋ฅผ ์ด์šฉํ•œ ์ง€ํ‘œ๋ ˆ์ด๋‹ค ์ž๋ฃŒ์˜ ์˜์ƒํ™”

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ž์›๊ณตํ•™๊ณผ,1998.Maste
    corecore